TrialIndian journal of dermatology, venereology and leprology

Safety and efficacy of methotrexate (0.3 mg/kg/week) versus a combination of methotrexate (0.15 mg/kg/week) with cyclosporine (2.5 mg/kg/day) in chronic plaque psoriasis: A randomised non-blinded controlled trial.

Satyendra Kumar Singh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.